Figure 3From: Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study Changes in median eGFR over time in the TDF+PI/r group, by eGFR normal (eGFR≥90 ml/min/1.73m 2 ) and abnormal (90>eGFR≥50 ml/min/1.73m 2 ) baselines. Back to article page